Evaluation of the early-phase [<sup>18</sup>F]AV45 PET as an optimal surrogate of [<sup>18</sup>F]FDG PET in ageing and Alzheimer's clinical syndrome.

Neuroimage Clin · 2021 · PMC8274342 · PMID 34247116

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

slightly non-significantno p-value reported

Brief description of the results based on PVE-corrected PET data Results were in accordance with those obtained from the PVE-non corrected PET data, despite (i) [ 18 F]FDG PET had slightly non-significant better performance in the binary classifications of eHC vs.

also in 109 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.